CanStroke Clinical Trials Platform
A Calgary-led national platform, CanStroke Recovery Trials, housed at UCalgary's Hotchkiss Brain Institute, led by Dr. Sean Dukelow, MD, PhD, brings together leading clinicians and researchers across Canada to test new approaches, therapies, and technologies to improve recovery from stroke. It is the world's first clinical trial platform of its kind.
In the five years since it was first established, CanStroke has attracted global attention as the launch pad to speed the pace of discovery. At the present time, there are nine stroke recovery trials running – studying everything from drug and exercise combinations to robotics.
With your support, we will expedite the research, support the training of clinicians, enable the expansion of trials and support the development of new trials on the platform.
More than 60 per cent of Canadians who have a stroke are left with some disability. There are 878,500 people living with stroke in Canada. The CanStroke platform has the potential to dramatically alter how stroke recovery is managed in Canada and around the world, over the next 10 years. Thank you for being a part of this journey.